Human leukocyte antigen profiles of latin american populations: differential admixture and its potential impact on hematopoietic stem cell transplantation

Bone Marrow Research
Esteban Arrieta-BolañosBronwen E Shaw


The outcome of hematopoietic stem cell transplantation (HSCT) is shaped by both clinical and genetic factors that determine its success. Genetic factors including human leukocyte antigen (HLA) and non-HLA genetic variants are believed to influence the risk of potentially fatal complications after the transplant. Moreover, ethnicity has been proposed as a factor modifying the risk of graft-versus-host disease. The populations of Latin America are a complex array of different admixture processes with varying degrees of ancestral population proportions that came in different migration waves. This complexity makes the study of genetic risks in this region complicated unless the extent of this variation is thoroughly characterized. In this study we compared the HLA-A and HLA-B allele group profiles for 31 Latin American populations and 61 ancestral populations from Iberia, Italy, Sub-Saharan Africa, and America. Results from population genetics comparisons show a wide variation in the HLA profiles from the Latin American populations that correlate with different admixture proportions. Populations in Latin America seem to be organized in at least three groups with (1) strong Amerindian admixture, (2) strong Caucasian component, and (...Continue Reading


May 1, 1995·Nature Medicine·J RubyI A Ramshaw
Dec 18, 1997·American Journal of Human Genetics·S L Bonatto, F M Salzano
Feb 12, 1998·Tissue Antigens·D ComasJ Bertranpetit
Oct 2, 1998·Tissue Antigens·S RendineE S Curtoni
Nov 30, 2000·Experimental and Clinical Immunogenetics·J TangR A Kaslow
Feb 13, 2001·Tissue Antigens·R de PabloJ Martín
Apr 11, 2001·Human Immunology·J A HollenbachWilliam Klitz
Sep 7, 2001·Human Immunology·Z LayrisseA Rodríguez-Larralde
Feb 1, 2002·Human Immunology·Francisco LoezaJulio Granados
Jul 18, 2002·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Steven C HoffmannPatrick J Blair
Dec 21, 2002·Transplantation Proceedings·E A Santiago-DelpínA Rodríguez-Trinidad
Jan 31, 2003·Annals of Human Genetics·B MoreraR Marin-Rojas
Feb 26, 2003·Human Genetics·Luis G Carvajal-CarmonaAndrés Ruiz-Linares
Mar 6, 2003·Immunogenetics·Gilberto Vargas-AlarcónA Arnaiz-Villena
Jun 26, 2003·Tissue Antigens·E Gomez-CasadoA Arnaiz-Villena
Jul 2, 2003·The Annals of Otology, Rhinology, and Laryngology·Ming-Wang HsiungHsing-Won Wang
Oct 11, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Derek S SernaFausto Loberiza
Mar 25, 2005·Tissue Antigens·A Arnaiz-VillenaJorge Martinez-Laso
Sep 8, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·K Scott BakerDaniel J Weisdorf
Oct 26, 2005·Photosynthesis Research·Christine A Raines
Jan 3, 2006·Human Immunology·Hélder SpínolaAntónio Brehm
Feb 17, 2006·Journal of Medical Virology·Nalini RamamurtyLi Jin
Mar 15, 2006·European Journal of Medical Genetics·Jorge Martinez-LasoA Arnaiz-Villena
Dec 16, 2006·Current Drug Targets·G Suarez-Kurtz, S D J Pena
Feb 7, 2007·Human Biology·Ines AlvarezPedro C Hidalgo
Mar 24, 2007·PLoS Medicine·Chantal BaronClaude Perreault
Sep 18, 2007·Human Immunology·Martin MaiersWilliam Klitz
Oct 2, 2007·Molecular Immunology·Rodrigo BarqueraJulio Granados
Oct 24, 2007·Clinical Rheumatology·Alessandro VolpeGuido Arcaro
Mar 29, 2008·PLoS Genetics·Michal LapidotYitzhak Pilpel
May 28, 2008·Best Practice & Research. Clinical Haematology·A M Dickinson, Ernst Holler
Nov 4, 2008·International Journal of Immunogenetics·A M Dickinson
Jan 17, 2009·Nature Chemical Biology·Herbert Waldmann
Apr 22, 2009·Annals of Human Biology·Alberto CintadoMarta Dueñas
Jun 6, 2009·International Journal of Immunogenetics·A Arnaiz-VillenaJ Moscoso
Jul 9, 2009·Bone Marrow Transplantation·P LjungmanEuropean Group for Blood and Marrow Transplantation
Oct 23, 2009·Tissue Antigens·William KlitzC K Hurley
Nov 10, 2009·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·K Scott BakerJ Douglas Rizzo
Nov 20, 2009·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Parameswaran N HariPaulette Mehta
Jan 15, 2010·Micron : the International Research and Review Journal for Microscopy·Kevin T Moore
Mar 26, 2010·Blood·Satoko MorishimaJapan Marrow Donor Program
Jun 22, 2010·British Journal of Haematology·Bronwen E ShawJ A Madrigal
Mar 1, 2009·Journal of Oncology Practice
Nov 11, 2010·Nucleic Acids Research·Faviel F Gonzalez-GalarzaAndrew R Jones
Apr 19, 2011·Journal of Epidemiology·Tulio C LinsRinaldo W Pereira
Sep 14, 2011·American Journal of Physical Anthropology·Keith Hunley, Meghan Healy


Jan 27, 2015·Pediatric Blood & Cancer·Yael Dinur-SchejterPolina Stepensky
Feb 5, 2013·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Daniel WolffHildegard T Greinix
Jul 22, 2017·HLA : Immune Response Genetics·M C F da Silva-MaltaM L Martins

Related Concepts

Graft-vs-Host Disease
Hematopoietic Stem Cells
Histocompatibility Antigens Class I
HLA Antigens
Risk Assessment

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.